Madagascar

Madagascar

Hepatitis B

Download HBV data

Prevalence of chronic HBV (HBsAg+)

National
Download
Value (%) Year Type Source
4.61 (4.02 - 5.21) 2019 Modelled IHME
4.62 (4.02 - 5.21) 2018 Modelled IHME
4.65 (3.98 - 5.29) 2017 Modelled IHME
4.93 (4.30 - 5.54) 2016 Modelled IHME
5.29 (4.64 - 5.97) 2015 Modelled IHME
5.48 (4.85 - 6.18) 2014 Modelled IHME
5.64 (5.01 - 6.34) 2013 Modelled IHME
5.78 (5.10 - 6.50) 2012 Modelled IHME
5.91 (5.18 - 6.69) 2011 Modelled IHME
6.04 (5.25 - 6.91) 2010 Modelled IHME
6.18 (5.39 - 7.06) 2009 Modelled IHME
6.32 (5.51 - 7.22) 2008 Modelled IHME
6.46 (5.64 - 7.40) 2007 Modelled IHME
6.6 (5.72 - 7.59) 2006 Modelled IHME
6.76 (5.78 - 7.80) 2005 Modelled IHME
6.95 (5.98 - 8.03) 2004 Modelled IHME
7.18 (6.21 - 8.32) 2003 Modelled IHME
7.41 (6.39 - 8.63) 2002 Modelled IHME
7.61 (6.50 - 8.87) 2001 Modelled IHME
7.72 (6.54 - 9) 2000 Modelled IHME
7.78 (6.56 - 9.03) 1999 Modelled IHME
7.83 (6.59 - 9.11) 1998 Modelled IHME
7.87 (6.63 - 9.18) 1997 Modelled IHME
7.9 (6.60 - 9.23) 1996 Modelled IHME
7.91 (6.62 - 9.28) 1995 Modelled IHME
7.91 (6.66 - 9.26) 1994 Modelled IHME
7.91 (6.68 - 9.22) 1993 Modelled IHME
7.91 (6.69 - 9.17) 1992 Modelled IHME
7.9 (6.69 - 9.19) 1991 Modelled IHME
7.89 (6.68 - 9.16) 1990 Modelled IHME
8.16 (6.54 - 10.11) 2015 Modelled WHO
Showing out of
Show more
Children under-5 years
Download
Value (%) Year Type Source
0.85 (0.60 - 1.13) 2019 Modelled IHME
0.89 (0.65 - 1.15) 2018 Modelled IHME
0.93 (0.68 - 1.22) 2017 Modelled IHME
1 (0.75 - 1.29) 2016 Modelled IHME
1.06 (0.79 - 1.37) 2015 Modelled IHME
1.09 (0.82 - 1.42) 2014 Modelled IHME
1.12 (0.83 - 1.44) 2013 Modelled IHME
1.15 (0.85 - 1.47) 2012 Modelled IHME
1.17 (0.86 - 1.51) 2011 Modelled IHME
1.19 (0.87 - 1.56) 2010 Modelled IHME
1.2 (0.89 - 1.58) 2009 Modelled IHME
1.21 (0.90 - 1.58) 2008 Modelled IHME
1.22 (0.91 - 1.58) 2007 Modelled IHME
1.24 (0.92 - 1.62) 2006 Modelled IHME
1.26 (0.94 - 1.66) 2005 Modelled IHME
1.66 (1.25 - 2.14) 2004 Modelled IHME
2.59 (1.94 - 3.33) 2003 Modelled IHME
3.69 (2.78 - 4.70) 2002 Modelled IHME
4.62 (3.45 - 5.93) 2001 Modelled IHME
5.04 (3.73 - 6.50) 2000 Modelled IHME
5.08 (3.79 - 6.56) 1999 Modelled IHME
5.12 (3.82 - 6.61) 1998 Modelled IHME
5.14 (3.84 - 6.65) 1997 Modelled IHME
5.16 (3.80 - 6.67) 1996 Modelled IHME
5.16 (3.79 - 6.74) 1995 Modelled IHME
5.16 (3.80 - 6.76) 1994 Modelled IHME
5.16 (3.79 - 6.74) 1993 Modelled IHME
5.15 (3.78 - 6.75) 1992 Modelled IHME
5.14 (3.74 - 6.78) 1991 Modelled IHME
5.12 (3.68 - 6.79) 1990 Modelled IHME
4.36 (3.06 - 5.91) 2015 Modelled WHO
Showing out of
Show more
Technical notes

Number of people living with chronic HBV

National
Download
Value Year Type Source
943,132 (798,532 - 1,095,330) 1990 Modelled IHME
970,030 (820,859 - 1,127,250) 1991 Modelled IHME
997,411 (843,842 - 1,155,780) 1992 Modelled IHME
1,025,360 (865,211 - 1,194,100) 1993 Modelled IHME
1,054,150 (886,761 - 1,233,380) 1994 Modelled IHME
1,084,120 (906,343 - 1,271,350) 1995 Modelled IHME
1,114,040 (930,932 - 1,301,240) 1996 Modelled IHME
1,142,660 (961,579 - 1,331,890) 1997 Modelled IHME
1,170,140 (984,769 - 1,360,150) 1998 Modelled IHME
1,196,710 (1,009,220 - 1,389,390) 1999 Modelled IHME
1,222,660 (1,035,490 - 1,425,550) 2000 Modelled IHME
1,240,330 (1,060,010 - 1,447,260) 2001 Modelled IHME
1,244,970 (1,073,660 - 1,448,440) 2002 Modelled IHME
1,241,900 (1,073,580 - 1,438,080) 2003 Modelled IHME
1,237,220 (1,063,690 - 1,428,460) 2004 Modelled IHME
1,237,830 (1,058,880 - 1,428,640) 2005 Modelled IHME
1,244,660 (1,077,530 - 1,430,210) 2006 Modelled IHME
1,253,060 (1,093,680 - 1,435,530) 2007 Modelled IHME
1,261,940 (1,100,880 - 1,441,620) 2008 Modelled IHME
1,270,100 (1,106,750 - 1,450,420) 2009 Modelled IHME
1,276,220 (1,109,310 - 1,458,640) 2010 Modelled IHME
1,282,230 (1,125,550 - 1,452,370) 2011 Modelled IHME
1,288,930 (1,139,020 - 1,451,330) 2012 Modelled IHME
1,292,990 (1,147,600 - 1,453,300) 2013 Modelled IHME
1,290,750 (1,141,290 - 1,455,190) 2014 Modelled IHME
1,278,250 (1,121,540 - 1,441,120) 2015 Modelled IHME
1,221,320 (1,064,440 - 1,374,070) 2016 Modelled IHME
1,182,240 (1,012,080 - 1,344,300) 2017 Modelled IHME
1,203,420 (1,047,000 - 1,357,760) 2018 Modelled IHME
1,230,460 (1,072,700 - 1,391,690) 2019 Modelled IHME
Showing out of
Show more

HBV-related death rate

National
Download
Value (per 100,000) Year Type Source
3.6 (2.41 - 5.29) 2019 Modelled IHME
3.6 (2.44 - 5.31) 2018 Modelled IHME
3.6 (2.42 - 5.29) 2017 Modelled IHME
3.57 (2.42 - 5.17) 2016 Modelled IHME
3.58 (2.43 - 5.12) 2015 Modelled IHME
3.77 (2.55 - 5.37) 2014 Modelled IHME
4.15 (2.84 - 5.90) 2013 Modelled IHME
4.6 (3.20 - 6.40) 2012 Modelled IHME
4.98 (3.47 - 6.85) 2011 Modelled IHME
5.2 (3.69 - 7.12) 2010 Modelled IHME
5.24 (3.76 - 7.19) 2009 Modelled IHME
5.23 (3.76 - 7.06) 2008 Modelled IHME
5.2 (3.74 - 7) 2007 Modelled IHME
5.28 (3.83 - 7.05) 2006 Modelled IHME
5.39 (3.93 - 7.11) 2005 Modelled IHME
5.5 (4.04 - 7.19) 2004 Modelled IHME
5.64 (4.16 - 7.38) 2003 Modelled IHME
5.75 (4.20 - 7.52) 2002 Modelled IHME
5.86 (4.32 - 7.72) 2001 Modelled IHME
5.99 (4.35 - 7.86) 2000 Modelled IHME
6.1 (4.46 - 8.02) 1999 Modelled IHME
6.26 (4.60 - 8.12) 1998 Modelled IHME
6.28 (4.61 - 8.13) 1997 Modelled IHME
6.33 (4.62 - 8.28) 1996 Modelled IHME
6.39 (4.61 - 8.40) 1995 Modelled IHME
6.49 (4.70 - 8.46) 1994 Modelled IHME
6.78 (4.95 - 8.87) 1993 Modelled IHME
6.76 (4.88 - 8.87) 1992 Modelled IHME
6.88 (4.99 - 8.94) 1991 Modelled IHME
6.98 (5.06 - 9.14) 1990 Modelled IHME
Showing out of
Show more
Technical notes

HBV-related deaths

National
Download
Value Year Type Source
960 (642 - 1,411) 2019 Modelled IHME
939 (635 - 1,384) 2018 Modelled IHME
914 (614 - 1,344) 2017 Modelled IHME
884 (599 - 1,282) 2016 Modelled IHME
865 (587 - 1,237) 2015 Modelled IHME
886 (601 - 1,263) 2014 Modelled IHME
952 (650 - 1,353) 2013 Modelled IHME
1,026 (714 - 1,428) 2012 Modelled IHME
1,082 (753 - 1,487) 2011 Modelled IHME
1,097 (780 - 1,503) 2010 Modelled IHME
1,075 (772 - 1,477) 2009 Modelled IHME
1,045 (751 - 1,409) 2008 Modelled IHME
1,009 (725 - 1,357) 2007 Modelled IHME
995 (722 - 1,329) 2006 Modelled IHME
987 (720 - 1,302) 2005 Modelled IHME
978 (719 - 1,279) 2004 Modelled IHME
975 (718 - 1,276) 2003 Modelled IHME
965 (706 - 1,263) 2002 Modelled IHME
956 (705 - 1,258) 2001 Modelled IHME
949 (689 - 1,245) 2000 Modelled IHME
939 (686 - 1,233) 1999 Modelled IHME
935 (688 - 1,214) 1998 Modelled IHME
912 (669 - 1,180) 1997 Modelled IHME
893 (652 - 1,167) 1996 Modelled IHME
876 (632 - 1,151) 1995 Modelled IHME
865 (626 - 1,127) 1994 Modelled IHME
878 (641 - 1,149) 1993 Modelled IHME
853 (616 - 1,118) 1992 Modelled IHME
845 (612 - 1,097) 1991 Modelled IHME
834 (605 - 1,093) 1990 Modelled IHME
937 2016 Modelled WHO
Showing out of
Show more
Technical notes

Percent of liver cancer deaths attributable to HBV

National
Download
Value (%) Year Type Source
33 (26 - 42) 2019 Modelled IHME
33 (26 - 42) 2018 Modelled IHME
33 (26 - 42) 2017 Modelled IHME
33 (26 - 42) 2016 Modelled IHME
33 (26 - 42) 2015 Modelled IHME
33 (26 - 42) 2014 Modelled IHME
34 (26 - 42) 2013 Modelled IHME
34 (26 - 43) 2012 Modelled IHME
34 (27 - 43) 2011 Modelled IHME
34 (27 - 43) 2010 Modelled IHME
34 (27 - 43) 2009 Modelled IHME
34 (27 - 43) 2008 Modelled IHME
34 (26 - 43) 2007 Modelled IHME
34 (26 - 42) 2006 Modelled IHME
34 (26 - 42) 2005 Modelled IHME
34 (26 - 42) 2004 Modelled IHME
34 (26 - 42) 2003 Modelled IHME
34 (26 - 42) 2002 Modelled IHME
34 (26 - 42) 2001 Modelled IHME
34 (26 - 42) 2000 Modelled IHME
34 (26 - 43) 1999 Modelled IHME
34 (26 - 43) 1998 Modelled IHME
34 (26 - 43) 1997 Modelled IHME
34 (26 - 43) 1996 Modelled IHME
33 (26 - 43) 1995 Modelled IHME
34 (26 - 43) 1994 Modelled IHME
34 (26 - 43) 1993 Modelled IHME
34 (26 - 42) 1992 Modelled IHME
33 (26 - 42) 1991 Modelled IHME
33 (25 - 42) 1990 Modelled IHME
Showing out of
Show more
Technical notes

Coverage of 3-dose hepatitis B vaccine

Infants
Download
Value (%) Year Type Source
75 2018 Survey/reported WHO/UNICEF
74 2017 Survey/reported WHO/UNICEF
77 2016 Survey/reported WHO/UNICEF
69 2015 Survey/reported WHO/UNICEF
73 2014 Survey/reported WHO/UNICEF
74 2013 Survey/reported WHO/UNICEF
70 2012 Survey/reported WHO/UNICEF
73 2011 Survey/reported WHO/UNICEF
70 2010 Survey/reported WHO/UNICEF
77 2009 Survey/reported WHO/UNICEF
77 2008 Survey/reported WHO/UNICEF
84 2007 Survey/reported WHO/UNICEF
82 2006 Survey/reported WHO/UNICEF
81 2005 Survey/reported WHO/UNICEF
71 2004 Survey/reported WHO/UNICEF
61 2003 Survey/reported WHO/UNICEF
51 2002 Survey/reported WHO/UNICEF
79 2019 Survey/reported WHO/UNICEF
Showing out of
Show more
Technical notes
HBV National Action Plan
HBV elimination goal
HepB birth dose policy
No
Eligible for HBV generic medicines
HCV National Action Plan
HCV elimination goal
Eligible for HCV generic medicines
At least one needle-syringe exchange program (NSP) operational
No
At least one opioid substitution therapy (OST) program operational
No
NSP in at least one prison
No
OST in at least one prison
No
% of substance use disorder facilities offering hepatitis testing
None
% of substance use disorder facilities offering hepatitis treatment
None

Hepatitis C

Download HCV data

Prevalence of chronic HCV (RNA+/cAg)

National
Download
Value (%) Year Type Source
1.07 (0.86 - 1.33) 2019 Modelled IHME
1.06 (0.86 - 1.32) 2018 Modelled IHME
1.06 (0.85 - 1.32) 2017 Modelled IHME
1.06 (0.86 - 1.32) 2016 Modelled IHME
1.06 (0.85 - 1.32) 2015 Modelled IHME
1.06 (0.85 - 1.31) 2014 Modelled IHME
1.05 (0.85 - 1.28) 2013 Modelled IHME
1.03 (0.83 - 1.26) 2012 Modelled IHME
1.01 (0.82 - 1.24) 2011 Modelled IHME
0.99 (0.80 - 1.22) 2010 Modelled IHME
0.97 (0.78 - 1.18) 2009 Modelled IHME
0.94 (0.76 - 1.14) 2008 Modelled IHME
0.91 (0.74 - 1.10) 2007 Modelled IHME
0.88 (0.72 - 1.07) 2006 Modelled IHME
0.88 (0.72 - 1.06) 2005 Modelled IHME
0.88 (0.72 - 1.06) 2004 Modelled IHME
0.88 (0.72 - 1.06) 2003 Modelled IHME
0.89 (0.73 - 1.07) 2002 Modelled IHME
0.9 (0.74 - 1.08) 2001 Modelled IHME
0.91 (0.75 - 1.10) 2000 Modelled IHME
0.94 (0.78 - 1.14) 1999 Modelled IHME
1 (0.82 - 1.22) 1998 Modelled IHME
1.06 (0.86 - 1.31) 1997 Modelled IHME
1.12 (0.90 - 1.39) 1996 Modelled IHME
1.14 (0.92 - 1.42) 1995 Modelled IHME
1.13 (0.91 - 1.42) 1994 Modelled IHME
1.12 (0.90 - 1.39) 1993 Modelled IHME
1.08 (0.87 - 1.35) 1992 Modelled IHME
1.03 (0.84 - 1.28) 1991 Modelled IHME
0.97 (0.78 - 1.20) 1990 Modelled IHME
Showing out of
Show more

Prevalence of anti-HCV

National
Download
Value (%) Year Type Source
1.2 (0.80 - 1.70) 2014 Modelled Gower et al, 2014
People who inject drugs (PWID)
Download
Value (%) Year Type Source
5.5 (2.10 - 9) 2012 Modelled Degenhardt L et al, 2017
Technical notes

Number of people living with chronic HCV (RNA+/cAg)

National
Download
Value Year Type Source
115,772 (93,184 - 142,849) 1990 Modelled IHME
126,907 (102,673 - 157,569) 1991 Modelled IHME
136,472 (110,141 - 169,850) 1992 Modelled IHME
144,496 (116,911 - 180,093) 1993 Modelled IHME
151,035 (121,733 - 189,092) 1994 Modelled IHME
156,167 (125,379 - 195,185) 1995 Modelled IHME
157,607 (127,219 - 195,621) 1996 Modelled IHME
154,514 (125,511 - 189,821) 1997 Modelled IHME
149,337 (122,267 - 182,121) 1998 Modelled IHME
144,839 (119,435 - 175,781) 1999 Modelled IHME
144,123 (118,736 - 173,805) 2000 Modelled IHME
146,547 (120,379 - 176,720) 2001 Modelled IHME
149,272 (121,962 - 179,731) 2002 Modelled IHME
152,388 (124,599 - 183,248) 2003 Modelled IHME
156,013 (127,604 - 187,996) 2004 Modelled IHME
160,275 (131,152 - 193,737) 2005 Modelled IHME
166,717 (136,061 - 200,801) 2006 Modelled IHME
176,093 (143,392 - 212,619) 2007 Modelled IHME
187,246 (151,893 - 227,306) 2008 Modelled IHME
198,865 (160,668 - 242,589) 2009 Modelled IHME
209,482 (168,870 - 256,962) 2010 Modelled IHME
219,437 (177,585 - 268,754) 2011 Modelled IHME
229,771 (186,037 - 280,831) 2012 Modelled IHME
239,907 (194,009 - 293,817) 2013 Modelled IHME
249,205 (200,835 - 308,121) 2014 Modelled IHME
256,974 (205,671 - 320,036) 2015 Modelled IHME
263,357 (212,762 - 326,270) 2016 Modelled IHME
269,752 (215,765 - 335,675) 2017 Modelled IHME
277,096 (223,074 - 343,262) 2018 Modelled IHME
285,380 (230,635 - 355,153) 2019 Modelled IHME
Showing out of
Show more

HCV-related death rate

National
Download
Value (per 100,000) Year Type Source
6.38 (4.34 - 9.01) 2019 Modelled IHME
6.36 (4.34 - 8.96) 2018 Modelled IHME
6.32 (4.35 - 8.92) 2017 Modelled IHME
6.25 (4.35 - 8.71) 2016 Modelled IHME
6.27 (4.40 - 8.68) 2015 Modelled IHME
6.27 (4.42 - 8.69) 2014 Modelled IHME
6.22 (4.40 - 8.55) 2013 Modelled IHME
6.15 (4.42 - 8.38) 2012 Modelled IHME
6.11 (4.40 - 8.28) 2011 Modelled IHME
6.15 (4.45 - 8.33) 2010 Modelled IHME
6.2 (4.53 - 8.31) 2009 Modelled IHME
6.21 (4.56 - 8.24) 2008 Modelled IHME
6.18 (4.54 - 8.18) 2007 Modelled IHME
6.28 (4.65 - 8.23) 2006 Modelled IHME
6.42 (4.80 - 8.44) 2005 Modelled IHME
6.51 (4.85 - 8.55) 2004 Modelled IHME
6.58 (4.92 - 8.58) 2003 Modelled IHME
6.59 (4.97 - 8.66) 2002 Modelled IHME
6.6 (5 - 8.66) 2001 Modelled IHME
6.7 (5.07 - 8.71) 2000 Modelled IHME
6.82 (5.10 - 8.74) 1999 Modelled IHME
7 (5.27 - 9.01) 1998 Modelled IHME
7.04 (5.27 - 9.04) 1997 Modelled IHME
7.11 (5.34 - 9.18) 1996 Modelled IHME
7.21 (5.40 - 9.33) 1995 Modelled IHME
7.14 (5.35 - 9.31) 1994 Modelled IHME
7.43 (5.59 - 9.59) 1993 Modelled IHME
7.39 (5.47 - 9.62) 1992 Modelled IHME
7.52 (5.57 - 9.85) 1991 Modelled IHME
7.65 (5.68 - 9.95) 1990 Modelled IHME
Showing out of
Show more
Technical notes

HCV-related deaths

National
Download
Value Year Type Source
1,702 (1,159 - 2,404) 2019 Modelled IHME
1,655 (1,130 - 2,334) 2018 Modelled IHME
1,605 (1,105 - 2,266) 2017 Modelled IHME
1,548 (1,079 - 2,158) 2016 Modelled IHME
1,515 (1,064 - 2,098) 2015 Modelled IHME
1,477 (1,041 - 2,047) 2014 Modelled IHME
1,426 (1,009 - 1,961) 2013 Modelled IHME
1,372 (985 - 1,871) 2012 Modelled IHME
1,326 (955 - 1,799) 2011 Modelled IHME
1,299 (941 - 1,759) 2010 Modelled IHME
1,273 (930 - 1,708) 2009 Modelled IHME
1,239 (911 - 1,645) 2008 Modelled IHME
1,199 (881 - 1,587) 2007 Modelled IHME
1,185 (877 - 1,551) 2006 Modelled IHME
1,176 (879 - 1,546) 2005 Modelled IHME
1,159 (864 - 1,521) 2004 Modelled IHME
1,137 (850 - 1,483) 2003 Modelled IHME
1,107 (835 - 1,455) 2002 Modelled IHME
1,076 (815 - 1,412) 2001 Modelled IHME
1,061 (802 - 1,379) 2000 Modelled IHME
1,049 (785 - 1,344) 1999 Modelled IHME
1,045 (787 - 1,345) 1998 Modelled IHME
1,022 (764 - 1,311) 1997 Modelled IHME
1,002 (753 - 1,295) 1996 Modelled IHME
988 (739 - 1,279) 1995 Modelled IHME
951 (712 - 1,240) 1994 Modelled IHME
963 (725 - 1,243) 1993 Modelled IHME
932 (690 - 1,212) 1992 Modelled IHME
923 (684 - 1,209) 1991 Modelled IHME
914 (679 - 1,190) 1990 Modelled IHME
737 2016 Modelled WHO
Showing out of
Show more
Technical notes

Percent of liver cancer deaths attributable to HCV

National
Download
Value (%) Year Type Source
21 (14 - 28) 2019 Modelled IHME
21 (14 - 28) 2018 Modelled IHME
21 (14 - 28) 2017 Modelled IHME
21 (14 - 28) 2016 Modelled IHME
21 (14 - 28) 2015 Modelled IHME
20 (14 - 28) 2014 Modelled IHME
20 (14 - 28) 2013 Modelled IHME
20 (14 - 27) 2012 Modelled IHME
20 (14 - 27) 2011 Modelled IHME
20 (14 - 27) 2010 Modelled IHME
20 (14 - 27) 2009 Modelled IHME
20 (14 - 27) 2008 Modelled IHME
20 (14 - 27) 2007 Modelled IHME
20 (14 - 27) 2006 Modelled IHME
20 (14 - 27) 2005 Modelled IHME
20 (14 - 28) 2004 Modelled IHME
20 (14 - 27) 2003 Modelled IHME
20 (14 - 27) 2002 Modelled IHME
20 (14 - 27) 2001 Modelled IHME
20 (14 - 27) 2000 Modelled IHME
20 (14 - 27) 1999 Modelled IHME
20 (14 - 27) 1998 Modelled IHME
20 (14 - 27) 1997 Modelled IHME
20 (14 - 27) 1996 Modelled IHME
20 (14 - 28) 1995 Modelled IHME
20 (14 - 27) 1994 Modelled IHME
20 (14 - 26) 1993 Modelled IHME
20 (14 - 26) 1992 Modelled IHME
20 (14 - 26) 1991 Modelled IHME
20 (14 - 26) 1990 Modelled IHME
Showing out of
Show more
Technical notes
HBV National Action Plan
HBV elimination goal
HepB birth dose policy
No
Eligible for HBV generic medicines
HCV National Action Plan
HCV elimination goal
Eligible for HCV generic medicines
At least one needle-syringe exchange program (NSP) operational
No
At least one opioid substitution therapy (OST) program operational
No
NSP in at least one prison
No
OST in at least one prison
No
% of substance use disorder facilities offering hepatitis testing
None
% of substance use disorder facilities offering hepatitis treatment
None

Overview

HBV elimination goal
HCV elimination goal

Prevalence (national)

Modelled

Survey/surveillance

No data available
No data available

Hepatitis related deaths (national)

Modelled

HBV
960
2019
(642 - 1,411)
IHME

Survey/surveillance

No data available
HBV chart

Modelled

HCV
1,702
2019
(1,159 - 2,404)
IHME

Survey/surveillance

No data available
HCV chart

Birth dose vaccination coverage (national)

Survey/surveillance

No data available

No. of syringes/PWID/year

Survey/surveillance

No data available
Eligible for HBV generic medicines
Eligible for HCV generic medicines